📊 IQV Key Takeaways
Is Iqvia Holdings Inc.. (IQV) a Good Investment?
IQVIA demonstrates solid operational fundamentals with 5.9% revenue growth, exceptional 62.8% gross margins, and strong $491M free cash flow generation. However, these strengths are undermined by aggressive leverage (2.25x debt/equity), weak liquidity (0.75x current ratio), and poor shareholder returns (4.4% ROE, 0.9% ROA), indicating capital structure mismanagement that erodes value despite operational quality.
IQVIA shows solid fundamental quality with mid-single-digit revenue growth, stable net income, expanding per-share earnings, and strong free cash flow generation. Profitability is healthy for its industry, with double-digit operating margins and strong returns on equity, but the balance sheet remains the main constraint given high leverage, weak current liquidity, and only moderate interest coverage.
Why Buy Iqvia Holdings Inc.. Stock? IQV Key Strengths
- Strong gross margins of 62.8% indicating pricing power and quality service business model
- Consistent revenue growth of 5.9% YoY demonstrating market demand
- Robust free cash flow generation of $491M with 11.8% FCF margin providing financial flexibility
- Consistent revenue growth supported by solid operating margin and resilient net margin
- Strong cash generation with $2.05B in free cash flow and a 12.6% FCF margin
- Healthy profitability profile, including 20.9% ROE and diluted EPS growth ahead of net income growth
IQV Stock Risks: Iqvia Holdings Inc.. Investment Risks
- Critical liquidity stress with current ratio of 0.75x (current liabilities exceed current assets)
- Excessive leverage at 2.25x debt/equity with thin 2.7x interest coverage creating refinancing vulnerability
- Net income essentially flat despite revenue growth (-0.1% YoY), with net margin (6.6%) significantly below operating margin (12.4%), indicating heavy interest expense burden destroying profitability
- High leverage with debt-to-equity of 2.14x and $13.88B of long-term debt
- Tight liquidity profile with current and quick ratios both at 0.75x
- Interest coverage of 3.0x leaves less room if rates stay high or operating income weakens
Key Metrics to Watch
- Debt-to-equity trajectory and deleveraging progress
- Operating cash flow sustainability and working capital trends
- Net income growth relative to revenue growth to assess interest burden impact
- Debt reduction and interest coverage improvement
- Sustained revenue growth translating into net income and free cash flow expansion
Iqvia Holdings Inc.. (IQV) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
IQV Profit Margin, ROE & Profitability Analysis
IQV vs Healthcare Sector: How Iqvia Holdings Inc.. Compares
How Iqvia Holdings Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Iqvia Holdings Inc.. Stock Overvalued? IQV Valuation Analysis 2026
Based on fundamental analysis, Iqvia Holdings Inc.. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Iqvia Holdings Inc.. Balance Sheet: IQV Debt, Cash & Liquidity
IQV Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Iqvia Holdings Inc..'s revenue has grown significantly by 18% over the 5-year period, indicating strong business expansion. The most recent EPS of $7.29 reflects profitable operations.
IQV Revenue Growth, EPS Growth & YoY Performance
IQV Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.8B | $249.0M | $1.40 |
| Q3 2025 | $3.9B | $285.0M | $1.55 |
| Q2 2025 | $3.8B | $266.0M | $1.54 |
| Q1 2025 | $3.7B | $249.0M | $1.40 |
| Q3 2024 | $3.7B | $285.0M | $1.55 |
| Q2 2024 | $3.7B | $297.0M | $1.59 |
| Q1 2024 | $3.7B | $288.0M | $1.53 |
| Q3 2023 | $3.6B | $283.0M | $1.49 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Iqvia Holdings Inc.. Dividends, Buybacks & Capital Allocation
IQV SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Iqvia Holdings Inc.. (CIK: 0001478242)
📋 Recent SEC Filings
❓ Frequently Asked Questions about IQV
What is the AI rating for IQV?
Iqvia Holdings Inc.. (IQV) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 63% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are IQV's key strengths?
Claude: Strong gross margins of 62.8% indicating pricing power and quality service business model. Consistent revenue growth of 5.9% YoY demonstrating market demand. ChatGPT: Consistent revenue growth supported by solid operating margin and resilient net margin. Strong cash generation with $2.05B in free cash flow and a 12.6% FCF margin.
What are the risks of investing in IQV?
Claude: Critical liquidity stress with current ratio of 0.75x (current liabilities exceed current assets). Excessive leverage at 2.25x debt/equity with thin 2.7x interest coverage creating refinancing vulnerability. ChatGPT: High leverage with debt-to-equity of 2.14x and $13.88B of long-term debt. Tight liquidity profile with current and quick ratios both at 0.75x.
What is IQV's revenue and growth?
Iqvia Holdings Inc.. reported revenue of $4.2B.
Does IQV pay dividends?
Iqvia Holdings Inc.. pays dividends, with $567.9M distributed to shareholders in the trailing twelve months.
Where can I find IQV SEC filings?
Official SEC filings for Iqvia Holdings Inc.. (CIK: 0001478242) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is IQV's EPS?
Iqvia Holdings Inc.. has a diluted EPS of $1.61.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is IQV a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Iqvia Holdings Inc.. has a BUY rating with 63% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is IQV stock overvalued or undervalued?
Valuation metrics for IQV: ROE of 4.4% (sector avg: 15%), net margin of 6.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy IQV stock in 2026?
Our dual AI analysis gives Iqvia Holdings Inc.. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is IQV's free cash flow?
Iqvia Holdings Inc..'s operating cash flow is $618.0M, with capital expenditures of $127.0M. FCF margin is 11.8%.
How does IQV compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 6.6% (avg: 12%), ROE 4.4% (avg: 15%), current ratio 0.75 (avg: 2).
Is Iqvia Holdings Inc.. carrying too much debt?
IQV has a debt-to-equity ratio of 2.25x, which is above the Healthcare sector average of 0.6x. Combined with a current ratio below 1, this warrants careful monitoring of the balance sheet.